Simile Valued at $2 Billion With $200 Million Funding

<p><strong>PALO ALTO<&sol;strong> &&num;8212&semi; Simile &&num;8212&semi; an AI-based simulation company &&num;8212&semi; has raised &dollar;200 million at a &dollar;2 billion post-money valuation&comma; co-led by Greenoaks and Index Ventures&comma; with participation by Hanabi&comma; Bain Capital Ventures&comma; A&ast;&comma; Factory&comma; CVS Health Ventures&comma; and Definition&period;<&sol;p>&NewLine;<p>Simile uses proprietary algorithms to design large-scale studies daily&comma; combining the resulting data with proprietary human behavior datasets to train AI models&period;<&sol;p>&NewLine;<p>The company launched five months ago and says it has grown revenues five times since then&period;<&sol;p>&NewLine;<p>Simile customers include&colon; CVS Health&comma; Wealthfront&comma; Deloitte and Gallup&period;<&sol;p>&NewLine;<p>&nbsp&semi;<&sol;p>&NewLine;